Assessing the Sensitivity of SureTouch™ in Women Undergoing Diagnostic and Screening Mammography
Assessing the Sensitivity of SureTouch™ in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography
Sponsor: George Washington University
Terminated
The benefit of completing the study was not worth exposing subjects to the risk during COVID. Delaying the return visits would make it difficult to analyze the changes in data overtime.
Other terminated trials from George Washington University
A NA clinical study on Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by George Washington University and has accumulated 6 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jul 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- George Washington University
- Sure, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .